High speed chronic total occlusion crossing devices

- Avinger, Inc.

An occlusion crossing device includes an outer shaft, an inner shaft, an optical fiber, and a handle attached to the inner shaft and the outer shaft. The inner shaft extends within the outer shaft. The inner shaft includes a drill tip at a distal end thereof. The optical fiber extends within the inner shaft substantially along a central axis of the inner shaft. The distal tip of the optical fiber is attached to the drill tip. The handle is configured to rotate the inner shaft and drill tip at speeds of greater than 500 rpm.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/516,093, filed on Jul. 18, 2019, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now U.S. Pat. No. 11,147,583, which is a continuation of U.S. patent application Ser. No. 15/324,325, filed on Jan. 6, 2017, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now U.S. Pat. No. 10,357,277, which is a U.S. National Phase Application Under 35 U.S.C. § 371 of International Application No. PCT/US2015/039585, filed on Jul. 8, 2015, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now International Publication No. WO 2016/007652, which claims priority to U.S. Provisional Patent Application No. 62/073,850, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” filed on Oct. 31, 2014 and U.S. Provisional Patent Application No. 62/022,101, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” filed on Jul. 8, 2014, the entire contents of each are incorporated by reference herein.

INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

BACKGROUND

Peripheral artery disease (PAD) and coronary artery disease (CAD) affect millions of people in the United States alone. PAD and CAD are silent, dangerous diseases that can have catastrophic consequences when left untreated. CAD is the leading cause of death for in the United States while PAD is the leading cause of amputation in patients over 50 and is responsible for approximately 160,000 amputations in the United States each year.

Coronary artery disease (CAD) and Peripheral artery disease (PAD) are both caused by the progressive narrowing of the blood vessels most often caused by atherosclerosis, the collection of plaque or a fatty substance along the inner lining of the artery wall. Over time, this substance hardens and thickens, which may interfere with blood circulation to the arms, legs, stomach and kidneys. This narrowing forms an occlusion, completely or partially restricting flow through the artery. Blood circulation to the brain and heart may be reduced, increasing the risk for stroke and heart disease.

Interventional treatments for CAD and PAD may include endarterectomy and/or atherectomy. Endarterectomy is surgical removal of plaque from the blocked artery to restore or improve blood flow. Endovascular therapies such as atherectomy are typically minimally invasive techniques that open or widen arteries that have become narrowed or blocked. Other treatments may include angioplasty to open the artery. For example, a balloon angioplasty typically involves insertion of a catheter into a leg or arm artery and positioning the catheter such that the balloon resides within the blockage. The balloon, connected to the catheter, is expanded to open the artery. Surgeons may then place a wire mesh tube, called a stent, at the area of blockage to keep the artery open.

Such minimally invasive techniques (e.g., atherectomy, angioplasty, etc.) typically involve the placement of a guidewire through the occlusion. Using the guidewire, one or more interventional devices may be positioned to remove or displace the occlusion. Unfortunately, placement of the guidewire, while critical for effective treatment, may be difficult. In particular, when placing a guidewire across an occlusion, it may be difficult to pass the guidewire through the occlusion while avoiding damage to the artery. For example, it is often difficult to prevent the guidewire from directing out of the lumen into the adventitia and surrounding tissues, potentially damaging the vessel and preventing effective treatment of the occlusion.

As a result, occlusion-crossing devices, intended to assist in the passing of the guidewire through the occlusion, have been developed. Many of the devices, however, are ill equipped to be used with imaging, thereby making placement of the guidewire cumbersome and difficult. Moreover, many of the occlusion-crossing devices are too large to be used in small-diameter peripheral arteries or in coronary arteries.

Accordingly, occlusion crossing catheter devices designed to address some of these concerns are described herein.

SUMMARY OF THE DISCLOSURE

Described herein are occlusion-crossing devices having a low profile and a distal drill tip. In some embodiments, an articulating feature can provide for steering or directionality of the device. In some embodiments, an inner shaft can be removable from an outer shaft.

In general, in one embodiment, an occlusion crossing device includes an outer shaft, an inner shaft, an optical fiber, and a handle attached to the inner shaft and the outer shaft. The inner shaft extends within the outer shaft. The inner shaft includes a drill tip at a distal end thereof. The optical fiber extends within the inner shaft substantially along a central axis of the inner shaft. The distal tip of the optical fiber is attached to the drill tip. The handle is configured to rotate the inner shaft and drill tip at speeds of greater than 500 rpm.

This and other embodiments can include one or more of the following features. The inner shaft and optical fiber can be removable from the outer shaft. The handle can include a luer lock configured to lock and unlock the inner shaft relative to the outer shaft. The outer shaft can include an articulating feature configured to allow the outer shaft to bend. The articulating feature can be activated by moving the inner shaft along the central axis relative to the outer shaft. The articulating feature can include a backbone and a plurality of circumferential cuts. The inner shaft can include an annular member configured to engage with an inner lip of the outer shaft to bend the outer shaft when the inner shaft is pushed distally. The inner shaft can include an annular member configured to engage with an inner lip of the outer shaft to bend the outer shaft when the inner shaft is pulled proximally. The outer shaft can include a preformed bend therein. The outer shaft can further include a marker positioned with respect to the preformed bend such that an orientation of the outer shaft can be determined during imaging. The outer shaft can include a transparent distal portion configured to allow imaging with the optical fiber therethrough. The handle can be configured to rotate the inner shaft and drill tip at speeds of greater than 1,000 rpm. The handle can be configured to rate the inner shaft and drill tip at speeds of greater than 500 rpm such that images can be generated from the optical fiber at a rate of greater than or equal to 8 frames per second. The optical fiber can be a common path optical coherence tomography fiber. The drill tip can include a plurality of spiral cutting edges. The drill tip can be a substantially smooth frusto-conical tip. The imaging device can further include a monorail guidewire lumen extending along the outer shaft. An outer diameter of the outer shaft can be less than 0.08 inches.

In general, in one embodiment, a method of crossing an occlusion includes: (1) inserting a device into a vessel having an occlusion therein; (2) rotating an inner shaft of the device relative to an outer shaft of the device such that a drill tip on the inner shaft drills through the occlusion; and (3) generating images with an optical fiber extending through the inner shaft at a rate of greater than or equal to 8 frames per second while rotating the inner shaft.

This and other embodiments can include one or more of the following features. The method can further include removing the inner shaft from the outer shaft, and inserting a guidewire through the outer shaft. The method can further include bending a distal end of the device in order to steer the device through the vessel. Bending the distal end can comprise pushing or pulling on the inner shaft. The method can further include orienting a bend in the outer shaft in a desired direction. The method can further include using a marker on the device to orient the bend. Rotating the inner shaft can comprise rotating at more than 500 rpm.

BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:

FIGS. 1A-3B show an occlusion crossing device having an articulating feature.

FIGS. 4A-5C show an occlusion crossing device having separable inner and outer shafts.

FIGS. 6A and 6B are exemplary block diagrams of drive systems for the catheters described herein.

FIGS. 7A-7B show an exemplary method for detecting the position of the driveshaft of a catheter.

FIGS. 8A-8B show articulation of an occlusion crossing device having an articulating feature and separable inner and outer shafts.

FIGS. 9A and 9B show the inner shaft of the occlusion crossing device of FIGS. 8A-8B positioned inside of the outer shaft for cutting and imaging.

FIG. 10 shows the outer shaft of the occlusion crossing device of FIGS. 8A-8B with the inner shaft removed.

FIGS. 11A and 11B show an exemplary handle for use with the occlusion crossing device of FIGS. 8A-8B.

FIGS. 12 and 13 show another exemplary handle for use with the occlusion crossing device of FIGS. 8A-8B.

FIGS. 14A-14C show the distal portion of another embodiment of an occlusion crossing device.

FIG. 15 shows the occlusion crossing device FIGS. 1A-3B with a monorail guidewire lumen.

 DETAILED DESCRIPTION

Described herein are occlusion-crossing devices having a low profile so as to be usable in small-diameter arteries and coronary arteries, e.g., through a 5 French catheter or smaller. In general, the devices described herein can have on-board imaging, such as optical coherence tomography (OCT) imaging. The optical fiber for OCT imaging can extend substantially along the central axis of the device, thereby decreasing the profile of the device and allowing for rotation at high speeds. The devices can also include a rotatable pointed tip, allowing for forward drilling. In some embodiments, the device can include an articulating distal end to enable steering of the device.

Referring to FIGS. 1A-3B, in one embodiment, an exemplary catheter 100 includes an outer shaft 122 and an inner driveshaft 131 connected to a distal tip 103. The elongate outer shaft 122 can be hollow and can have an inner diameter of approximately 1 mm and an outer diameter of approximately 1.5 mm. In some embodiments, the outer shaft 122 can have a coiled construction, whereby the coils are wound by laying one coil over another. For example, the shaft 122 can include at least two coil layers. Further, the coil layers can be counter-wound, such that one coil layer, such as the inner coil layer, has a left hand lay and another layer, such as the outer coil layer, has a right hand lay. The coil can provide torque in the direction that tightens the outer layer, cinching down on the inner layer. A third counter wound coil can be added to generate torque in both directions. In another embodiment, the shaft 122 is made of a braided wire reinforced polymeric shaft. In yet another embodiment, the shaft 122 can be a laser-cut tube. The outer shaft 122 can further include one or more imaging windows 144 at a distal end thereof.

A bushing 124 (see FIG. 1D) can be attached to the shaft 122, such as through a tab and slot mechanism 148. The bushing 124 can act as a bearing surface relative to the inner shaft or tip 103. Further, the bushing 124 can include edges or lips 151, 152 on either side configured to interact with the inner driveshaft 131 or the tip 103, as discussed further below.

The tip 103 can be configured, for example, to separate, dissect, or shred tissue. In some embodiments, the tip 103 can include sharp spiraling flutes 113 that come to a point in the center of the device. Further, the flutes 113 can be angled such that they have sharper edges when rotated in one direction than in another direction. As a result, the tip 103 with flutes 113 can have an active and passive modes depending upon the direction of rotation of the tip 103. In passive mode, the tip 103 with flutes 113 can be less aggressive, providing blunt dissection of tissue. In active mode, the tip 103 with flutes 113 can be more aggressive, providing cutting and auguring to make its way through harder material. In some embodiments, as described further below with respect to FIGS. 14A and 14B, the distal tip 103 can have a smooth angled surface that is non-fluted.

The inner driveshaft 131 (see FIG. 1D) can be connected to the distal tip 103 and can extend down the center of the outer shaft 122. The inner driveshaft 131 can be configured to rotate in either a single direction or in both the clockwise and counterclockwise directions so as to rotate the tip 103 relative to the shaft 122 (about the bushing 124) in either a single direction or in the clockwise or counterclockwise direction. Annular rings 174, 172 can be positioned around a distal portion of the inner driveshaft 131 and/or the tip 103. The rings 174, 172 can be positioned against the edges 151, 152 of the bushing 124. The annular bushing 124 can allow relative rotation of the inner driveshaft 131 relative to the bushing 124 while preventing axial movement (and allowing for articulation in some embodiments, as described further below).

In some embodiments, a distal portion of the outer shaft 122 can include an articulating feature 145. As shown in FIGS. 1A and 1B, the articulating feature 145 can include one or more backbones 245a,b and a series of circumferential cuts 247 and 295. The one or more backbones can be positioned on only one side of the catheter (e.g., span less than 180 degrees, less than 150 degrees, or less than 90 degrees). In some embodiments, and as shown in FIG. 1A, a series of small circumferential cuts 295 can extend between the two backbones 245a,b in order to provide added flexibility during bending. The circumferential cuts 247, 295 can be configured as incomplete rings or spirals about the outer shaft 122. Referring to FIG. 1B, in some embodiments, the circumferential cuts 247 can include one or more breaks 297a,b therein designed to provide additional tensile strength and compression resistance for the articulating feature 145.

The articulating feature 145 can be attached to the inner driveshaft 131 such that movement of the driveshaft 131 can activate the articulating feature. Further, in some embodiments, a handle 200 (see FIGS. 2B and 3B) can be used to activate movement of the driveshaft 131.

Referring to FIGS. 2A-2B, as the driveshaft 131 is pushed distally, the annular ring 172 can push distally on the proximal lip 152 of the bushing 124 (see FIG. 1D), causing the circumferential cuts 247 to spread apart or open while the backbones 245a,b maintain their length (and the circumferential cuts 295 move closer together). As a result, the articulating feature 145 can bend towards the backbones 245a,b. As shown in FIG. 2B, this bending mechanism can be activated on the handle 200, such as by moving a ring 303 distally and/or pushing or moving a button or lever.

Likewise, referring to FIGS. 3A-3B, as the driveshaft 131 is pulled proximally, the annular ring 174 can hit the distal lip 151 of the bushing 124. As further distal force is applied by the driveshaft 131, the circumferential cuts 247 can begin to move closer together and/or the material between the cuts 247 can overlap while the backbones 245a,b maintain their length (and the cuts 295 move further apart). As a result, the articulating feature 145 can bend towards the circumferential cuts 247 and away from the backbones 245a,b. As shown in FIG. 3B, this bending mechanism can be activated on the handle 200, such as by moving the ring 303 proximally and/or pushing or moving a button or lever.

The bending movement of the articulating feature 145 can advantageously allow the device 100 to be steered when used in the vessel, such as for re-entry if the tip extends out of the occlusion or lumen. In some embodiments, the catheter 100 can be configured to bend in only one direction by either pushing or pulling on the driveshaft 131 and return to the straight configuration shown in FIG. 1A by movement of the driveshaft 131 in the opposite direction.

The catheter 100 can further include an imaging element 199 attached to the driveshaft 131 and configured to rotate therewith. The imaging element 199 can be the distal end of an OCT fiber 119 extending down the center of the driveshaft 131. The imaging element 199 can provide imaging (through windows 144) as the catheter 100 is used in the vessel, thereby assisting in occlusion crossing.

Referring to FIG. 15, in some embodiments, a monorail guidewire lumen 1505 can extend along the outer shaft 122. The guidewire lumen 1505 can run, for example, between the two backbones 245a,b so as to not add additional stiffness to the flexible area with the circumferential cuts 247.

In some embodiments, the catheter 100 can be used with a sheath. The sheath can be hollow and include a hemostasis valve attached at the proximal end with a flush port on the side to facilitate flushing through the sheath. The sheath can also facilitate guidewire placement to the target site, particularly for embodiments of the catheter 100 that do not include a monorail guidewire lumen. That is, the catheter 100 can be used to cross the occlusion, the sheath can be placed thereover, the device removed, and then the guidewire can be introduced.

Referring to FIGS. 4A-5C, in another embodiment, an exemplary catheter 300 includes an inner shaft 311, an outer shaft 322, and a distal tip 303 connected to the inner shaft 311. Further, the outer shaft 322 can be separable from the inner shaft 311. For example, the inner shaft 311 can include a luer connector near the proximal end that is attachable and detachable from a luer connector on a proximal end of the outer shaft 322, as described below with respect to handle 900.

In some embodiments, a distal portion 313 of the outer shaft 322 can be clear or transparent, such as made of a clear or transparent plastic, in order to allow imaging therethrough. In some embodiments, the outer shaft 322 can further include a preformed bend 329 therein to help orient or steer the device. A marker 315, such as a metal marker, can extend within the distal portion 313 to indicate the relative orientation of the catheter 300 when in use. For example, as shown in FIG. 4B, the innermost portion of the bend 329 can align with the marker 315.

Further, in some embodiments, the inner shaft 311 can move longitudinally within the hollow outer shaft 322 by sliding a ring on a handle (such as handle 200) connected to the catheter 300 to allow the inner shaft 311 to be exposed (as shown in FIGS. 4A-4B) or fully covered (as shown in FIGS. 5A-5C). In use, the inner shaft 311 can thus be extended out of the outer shaft to help drill through the occlusion and pulled in when dissection is not required (or when only blunt dissection is required). In some embodiments, the inner shaft 311 can be configured to be fixed at various points relative to the outer shaft 322 so as to vary the amount of exposed tip 103. Further, the shaft 311 can be fully removed from the outer shaft 322 to allow for placement of a guidewire therethrough.

Further, the device 300 can include an imaging element 399 similar to as described above with respect to device 100. The catheter 300 can be configured to image with the imaging element 399 both when the inner shaft 311 is extended distally out of the outer shaft 322 and when the inner shaft 311 is positioned within the outer shaft 322 (through the transparent distal portion 313).

The device 300 can further or alternatively include any of the features, materials, and/or dimensions described above with respect to device 100.

Referring to FIGS. 8A-10, in another embodiment, an exemplary catheter 800 can include both a separable inner shaft 811 and outer shaft 822 and an articulating feature 845 on the distal end of the outer shaft 822.

Referring to FIGS. 8A-8B, the articulating feature 845 can include a backbone 945 and a series of circumferential cuts 947. Further, as shown in FIG. 9A, a collar 860 attached to the outer shaft 822 can include an inner ledge 862 configured to extend radially inwards relative to the outer shaft 822. Likewise, the inner shaft 811 can include an annular member 872, such as a plastic bearing, that has a greater diameter than the rest of the inner shaft 811. Thus, when the inner shaft 811 is pushed distally, the annular member 872 of the inner shaft 811 can push against the inner ledge 862 of the collar 860. As a result, the outer shaft 822 can bend at the cuts 947 towards the backbone 945 (as shown by the arrows in FIG. 9A).

As shown in FIG. 10, the inner shaft 811 can be fully removable from the outer shaft 822 and collar 860 by pulling the inner shaft 811 proximally. By doing so, the outer shaft 822 can be used as a sheath, e.g., for guidewire placement.

Further, the inner shaft 811 can include an imaging element 877 element similar to as described above with respect to devices 100 and 300 that is rotatable with the inner shaft 811. The imaging element 877 can image through imaging windows 866 in the collar 860. Further, the inner ledge 862 can also function to properly align the imaging element 877 with the imaging windows 866 when the inner shaft 811 is within the outer shaft 822.

The inner shaft 811 can include a rotatable distal tip 803 similar to as described above with respect to devices 100 and 300. Likewise, the device 800 can alternatively or additionally include any of the materials and dimensions described above with respect to devices 100 and 300.

Referring to FIGS. 11A-11B, a handle 900 can be used to operate the device 800. The handle 900 can include a luer lock 883 configured to lock the inner shaft 811 and outer shaft 822 together longitudinally. The luer lock 883 can be configured to provide some relative longitudinal movement between the outer shaft 822 and the inner shaft 811 such that the inner shaft 811 can still move a small distance, such as between about 0.125 inches to 0.2 inches, to activate the articulating feature 845. For example, the inner shaft 811 can include an accordion or elastomeric segment to provide the additional relative movement. The actual displacement distance depends on the diameter of the outer shaft of the catheter, the degree of bending that is desired and the elongation/compression of the outer and inner shaft, respectively. The larger the diameter of the outer shaft, the greater the desired degree of bending, and the more compression/elongation of the shafts, the greater the required amount of displacement. Further, the luer lock 883 can be configured to allow the inner shaft 811 to rotate freely within the outer shaft so as to provide rotation of the sharp distal tip 803 connected to the inner shaft 811. The luer lock 883 can be configured such that the outer shaft can be rotated relative to the position of the handle. With the shaft in the articulated position, rotating the outer shaft will direct the catheter around or towards obstacles during use. If the luer lock 883 is disconnected, as shown in FIG. 11B, the inner shaft 811 can be pulled out of the outer shaft 822 by the handle, leaving the outer shaft 822 in place, such as for guidewire placement.

The handle 900 can further include a lever 885 or ring configured to control the axial movement of the inner shaft 811 (and thus the articulation of the device 800). In some embodiments, the lever 885 can include a locking mechanism that allows the device 800 to stay bent at a set angle. The handle 900 can also include a rotation element 893 attached to the outer shaft 822 and configured to rotate the outer shaft 822, such as 360 degrees, to position the bend of the device 800 in the desired orientation.

Another exemplary handle 1000 is shown in FIGS. 12-13. The handle 1000 can include many of the features of handle 900. A slide button 1085 can be used to control the axial movement of the inner shaft. The rotation element 1093 can be configured to rotate the outer shaft 822.

Furthermore, in some embodiments, the connection between the outer and inner shafts within the handle can be configured such that the two shaft snap together, axially fixing the proximal ends together, but allowing them to rotate independently. In other embodiments, a third element could be used to key, link, or peg the two shafts together.

Features of the handles 900, 1000, though described for use with catheter 800, can likewise be used with catheters 100, 300.

The distal end of another embodiment of a catheter 1400 is shown in FIGS. 14A-14B. The catheter 1400 is similar to catheters 100, 300, 800 except that it includes a smooth distal tip 103 and a molded distal portion 1410. Thus, the distal tip 103 can have a smooth angled surface 1413 that is non-fluted and comes together in a slightly convex distal point 1415 (i.e., the tip can be frusto-conical). The distal tip 103 of FIGS. 14A, 14B can advantageously provide less aggressive drilling through the occlusion. The distal tip 103 of FIGS. 14A and 14B can be used in place of any of the distal tips described with respect to catheters 100, 300, 800. Likewise, the catheter 1400 can include a molded distal portion 1422. The molded distal portion 1422 can be similar to the distal end of the catheter 300 and can include a bushing 1424, a transparent section 1422, and the scaffolding 1452 of the outer shaft. Further, an imaging fiber 1499 can run down the central axis of the device, as described above with respect to other embodiments. Any of the features of catheter 100, 300, 800 can be used in addition to, or as an alternative to, the features described with respect to catheter 1400. Likewise, the catheter 1400 can be used with a handle having some or all of the features of handles 200, 900, or 1000.

In some embodiments, all or a portion of the outer shaft of the catheters described herein can be clear to allow imaging therethrough. Further, in some embodiments, the catheters described herein can include a balloon to occlude for better imaging. The balloon can be a clear balloon to allow imaging therethrough.

As described above, the catheters 100, 300, 800, 1400 can include an imaging element. The imaging element can include an optical fiber, such as an optical coherence tomography (OCT) imaging fiber. The optical fiber can extend within the driveshaft or inner shaft so as to extend substantially along the central axis of the catheter for the entire length of the fiber. The fiber can be attached at the distal end of the driveshaft or inner shaft and/or the distal tip, but can be otherwise free to float within the driveshaft. The imaging fiber can transfer an OCT signal for imaging of the vessel in which the device is placed. In some embodiments, the imaging fiber can have a polyimide coating therearound within the length of the driveshaft to support and protect the fiber as it spins within the driveshaft. Further, the handles described herein can be configured to accommodate a certain amount of slack in the fiber to facilitate extension and retraction of drive shaft against hollow shaft.

The imaging element can further include a mirror oriented at an angle (such as a 30-60 degree angle, e.g., 45 degrees) with respect to the central axis of the fiber such that light coming out of the fiber will bounce off the mirror and into the adjacent tissue. Glue can be used to hold the distal end of the optical fiber in place. The glue can have a refractive index configured to be appropriately mismatched with the refractive index of the fiber, as described in U.S. patent application Ser. No. 12/790,703, titled “OPTICAL COHERENCE TOMOGRAPHY FOR BIOLOGICAL IMAGING,” filed May 28, 2010, Publication No. US-2010-0305452-A1; and International Patent Application No. PCT/US2013/031951, titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” filed Mar. 15, 2013, both of which are incorporated by reference in their entireties. Further, the glue can have a meniscus shape along its outer edge, as described in International Patent Application No. PCT/US2013/031951 titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” filed Mar. 15, 2013, incorporated by reference herein. The meniscus shape can advantageously ensure that the light reflected back from the surface of the glue and back into the fiber is significantly less than the light referenced.

The driveshaft or inner shaft, and thus the imaging element or optical fiber, can be configured to rotate continuously at high speeds, such as greater than 500 rpm, greater than 600 rpm, greater than 700 rpm, greater than 800 rpm, greater than 900 rpm, or greater than 1,000 rpm, e.g., between 500-1,000 rpm, in one or both directions to provide OCT imaging around the inner circumference of the vessel. Such high speed rotation in a single direction or in different directions as chosen by the user (as opposed to requiring rotation alternately in both directions to manage the optical fiber) allows for the gathering of image data more quickly, thereby providing more accurate and up-to-date images during use of the device 100. For example, images can be generated at a rate of greater than 6 frames per section (fps), such as greater than or equal to 8 fps or greater than or equal to 10 fps, such as approximately 16.67 fps. In an exemplary embodiment, the rate of Laser sweep, such as approximately 20 KHz, can be configured to keep up with at 16.67 frames per second with about 1200 lines per frame.

Advantageously, because the optical fiber runs through the center of the catheters described herein, the catheters can be small in diameter. For example, the outer diameter of the catheters described herein can be less than 0.10″, such as less than 0.08″, such as less than 0.07″, less than 0.06″, or less than 0.05″. Accordingly, the catheters described herein can advantageously be used in small-diameter peripheral arteries and coronary arteries.

In some embodiments, the catheters described herein can be configured to be attached to a drive system. The drive system can include a rotary optical junction configured to rotate the fiber. Exemplary drive systems that could be used in conjunction with the devices herein are described in U.S. patent application Ser. No. 13/654,357, titled “ATHERECTOMY CATHETERS AND NON-CONTACT ACTUATION MECHANISM FOR CATHETERS,” filed Oct. 17, 2012 and International Patent Application No. PCT/US2013/032089, titled “ATHERECTOMY CATHETER DRIVE ASSEMBLIES,” filed Mar. 15, 2013, each incorporated herein by reference in its entirety.

In some embodiments, the drive system can communicate with the control system via a communication bus, which in some embodiments can be a CAN bus 2.0B. This communication can be employed to convey status to the control system or console, such as direction, speed, run status, and other information. It can also be employed to send control information to the drive system, such as run command, speed, direction, and setting of parameters for compensations of mechanical characteristics of the catheters. Referring to FIG. 6A, in one embodiment, a drive processor 1601 is used as the main controlling element for the drive system. The drive processor 1601 controls the motor 1603 through a motor controller 1602, which receives commands and returns status from/to the drive processor 1601. The drive processor 1601 can, in addition to simple speed and direction control, also implement algorithms to optimize catheter performance. The drive processor 1601 communicates with the control system (e.g., the console for the device) via the CAN controller 1604 to send and receive commands and status. In addition, in this embodiment a switch 1605 on the drive processor 1601 housing allows local control of the run state. The switch 1605 can be replaced with alternative hardware inputs, such as buttons, toggles, or knobs.

Further, in some embodiments the drive system can communicate with the catheter via NFC or RFID to obtain information about the catheter. As an example, this information can include catheter type, optimal rotational speed and direction, serial number, amongst many possible parameters. Referring to FIG. 6B, the drive system communicates with the catheter via a NFC/RFID reader 1606 and a NFC/RFID tag 1607 in the catheter to obtain information stored in the tag.

The drive system can be configured to allow the driveshaft and cutter to rotate continuously in the clockwise or the counterclockwise direction depending upon user preference. Therefore, in some embodiments, the drive system can include a user-addressable switch, such as a toggle, to set the desired direction.

Further, in some embodiments, the drive system can include a mechanism to determine the amount of rotation of the driveshaft in the clockwise or counterclockwise directions. Referring to FIGS. 6A and 6B, in one embodiment, for example, the drive system can provide information related to the direction of the motor. Speed and direction can be sensed by the control system (or console) by a data line in the umbilical, which can be a dedicated line or a multiplexed signal. The dedicated line can carry an analog or a digital signal. In one embodiment, a dedicated voltage line carries six discrete velocities (vector speed+direction) that are interpreted by the control system or console in order to infer speed and direction of the catheter.

Referring to FIGS. 7A-7B, in on embodiment, a flag in the drive system can include either an asymmetric design or an asymmetric positioning of the flags around the motor (see FIG. 7A). A controller can then sense motor direction by detecting the distinct series of flag spacing and/or width, as shown in FIG. 7B.

Further, in some embodiments, the drive system can be configured to rotate the driveshaft at several discrete rates and/or include a knob to allow for user-chosen continuously variable speeds.

Any of the catheters described herein can be shape-set or include shape-set features to enhance trackability and navigability.

As used herein, an imaging element can include the OCT optical fiber, such as the distal end of the optical fiber, as well as the mirror and adhesive used to hold the mirror and optical fiber in place.

As described above, the catheters described herein can include optical coherence tomography imaging, such as common path OCT. Such OCT systems are described in U.S. patent application Ser. No. 12/829,267, titled “CATHETER-BASED OFF-AXIS OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM,” filed Jul. 1, 2010, Publication No. US-2010-0021926-A1; U.S. patent application Ser. No. 12/790,703, titled “OPTICAL COHERENCE TOMOGRAPHY FOR BIOLOGICAL IMAGING,” filed May 28, 2010, Publication No. US-2010-0305452-A1; and International Patent Application PCT/US2013/031951 titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” filed Mar. 15, 2013, all of which are incorporated by reference in their entireties. Alternatively, other types of imaging could be used with the catheters described herein. For example, the devices described herein could be configured to work with infrared spectroscopy or ultrasound.

The catheters 100, 300, 800, 1400 described herein can be used for occlusion-crossing within blood vessels. Advantageously, the devices can advantageously provide increased trackability through bending/steering and high imaging speed during such crossing.

Additional details pertinent to the present invention, including materials and manufacturing techniques, may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.

When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.

Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.

Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.

Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.

As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.

Claims

1. An occlusion crossing device comprising:

a catheter comprising: a driveshaft having a distal end with a drill tip; and an outer shaft having a lumen configured to accommodate the driveshaft and to allow the driveshaft to rotate therein; and
a handle attached to a proximal end of the catheter, the handle comprising: a lock configured to transition between a locked configuration and an unlocked configuration, wherein the lock in the locked configuration locks the driveshaft relative to the outer shaft, and wherein the lock in the unlocked configuration enables the driveshaft to be removed from the outer shaft; and a button or ring configured to control bending of the catheter when the lock is in the locked configuration, wherein actuation of the button or ring causes a longitudinal force to be applied on the driveshaft relative to the outer shaft to bend the catheter.

2. The occlusion crossing device of claim 1, wherein the lock in the locked configuration provides a set amount of longitudinal movement of the driveshaft relative to the outer shaft to enable bending of the catheter.

3. The occlusion crossing device of claim 1, wherein the outer shaft includes a backbone configured to bend the outer shaft in a predetermined direction when the longitudinal force is applied to the driveshaft.

4. The occlusion crossing device of claim 1, wherein an inner portion of the outer shaft is configured to engage with the driveshaft when the longitudinal force is applied to the driveshaft relative to the outer shaft.

5. The occlusion crossing device of claim 1, wherein the button or ring is a slideable button.

6. The occlusion crossing device of claim 1, wherein the button or ring is a ring that is distally and proximally movable.

7. The occlusion crossing device of claim 1, wherein the lock in the locked configuration allows the driveshaft to rotate relative to the outer shaft.

8. The occlusion crossing device of claim 1, wherein the outer shaft includes an articulating feature configured to allow the outer shaft to bend when the longitudinal force to be applied on the driveshaft relative to the outer shaft.

9. The occlusion crossing device of claim 8, wherein the articulating feature includes a backbone and a plurality of circumferential cuts.

10. The occlusion crossing device of claim 1, wherein the lumen of the outer shaft is sized and shaped to accommodate a guidewire therein when the driveshaft is removed from the lumen.

11. The occlusion crossing device of claim 1, wherein the driveshaft comprises an optical fiber adapted to generate images.

12. The occlusion crossing device of claim 11, wherein the optical fiber is configured to rotate with the driveshaft.

13. The occlusion crossing device of claim 11, wherein the driveshaft further comprises an imaging element at a distal end of the optical fiber.

14. A method of crossing an occlusion, comprising:

inserting a catheter into a patient's vessel having the occlusion therein, the catheter having a driveshaft within a lumen of an outer shaft and rotatably coupled to the outer shaft;
actuating a lock of a handle to connect the driveshaft to the outer shaft;
actuating a button or ring of the handle at a proximal end of the catheter while the lock is actuated to cause a longitudinal force to be applied on the driveshaft relative to the outer shaft to bend the catheter;
unlocking the lock to disconnect the driveshaft from the outer shaft; and
removing the driveshaft from the outer shaft when the driveshaft is unlocked from the outer shaft.

15. The method of claim 14, wherein bending the catheter comprises bending a distal end of the catheter.

16. The method of claim 14, further comprising generating images using an optical fiber coupled to the driveshaft.

17. The method of claim 16, wherein the images are generated when the driveshaft is rotating.

18. The method of claim 14, further comprising inserting a guidewire within the lumen of the outer shaft after removing the driveshaft from the outer shaft.

Referenced Cited
U.S. Patent Documents
3367727 February 1968 Ward et al.
3908637 September 1975 Doroshow
4178935 December 18, 1979 Gekhaman et al.
4487206 December 11, 1984 Aagard
4527553 July 9, 1985 Upsher
4552554 November 12, 1985 Gould et al.
4578061 March 25, 1986 Lemelson
4598710 July 8, 1986 Kleinberg et al.
4611600 September 16, 1986 Cohen
4621353 November 4, 1986 Hazel et al.
4639091 January 27, 1987 Huignard et al.
4651753 March 24, 1987 Lifton
4654024 March 31, 1987 Crittenden et al.
4681106 July 21, 1987 Kensey et al.
4686982 August 18, 1987 Nash
4691708 September 8, 1987 Kane
4729763 March 8, 1988 Henrie
4771774 September 20, 1988 Simpson et al.
4781186 November 1, 1988 Simpson et al.
4808163 February 28, 1989 Laub
4841977 June 27, 1989 Griffith et al.
4842578 June 27, 1989 Johnson et al.
4850354 July 25, 1989 McGurk-Burleson et al.
4857046 August 15, 1989 Stevens et al.
4920961 May 1, 1990 Grossi et al.
4926858 May 22, 1990 Gifford, III et al.
5000185 March 19, 1991 Yock
5002560 March 26, 1991 Machold et al.
5018529 May 28, 1991 Tenerz et al.
5041082 August 20, 1991 Shiber
5047040 September 10, 1991 Simpson et al.
5085662 February 4, 1992 Willard
5099850 March 31, 1992 Matsui et al.
5178153 January 12, 1993 Einzig
5182291 January 26, 1993 Gubin et al.
5190050 March 2, 1993 Nitzsche
5192291 March 9, 1993 Pannek, Jr.
5217479 June 8, 1993 Shuler
5312415 May 17, 1994 Palermo
5312425 May 17, 1994 Evans et al.
5321501 June 14, 1994 Swanson et al.
5333142 July 26, 1994 Scheps
5358472 October 25, 1994 Vance et al.
5366464 November 22, 1994 Belknap
5372601 December 13, 1994 Lary
5383460 January 24, 1995 Jang et al.
5383467 January 24, 1995 Auer et al.
5425273 June 20, 1995 Chevalier
5425371 June 20, 1995 Mischenko
5429136 July 4, 1995 Milo et al.
5431673 July 11, 1995 Summers et al.
5437284 August 1, 1995 Trimble
5449372 September 12, 1995 Schmaltz et al.
5459570 October 17, 1995 Swanson et al.
5460168 October 24, 1995 Masubuchi et al.
5465147 November 7, 1995 Swanson
5507725 April 16, 1996 Savage et al.
5507760 April 16, 1996 Wynne et al.
5507795 April 16, 1996 Chiang et al.
5517998 May 21, 1996 Madison
5529580 June 25, 1996 Kusunok et al.
5556405 September 17, 1996 Lary
5607394 March 4, 1997 Andersen et al.
5613981 March 25, 1997 Boyle et al.
5620426 April 15, 1997 Braithwaite
5632754 May 27, 1997 Farley et al.
5632755 May 27, 1997 Nordgren et al.
5674232 October 7, 1997 Halliburton
5676012 October 14, 1997 Ceriale
5681336 October 28, 1997 Clement et al.
5690634 November 25, 1997 Muller et al.
5722403 March 3, 1998 McGee et al.
5728148 March 17, 1998 Bostrom et al.
5749846 May 12, 1998 Edwards et al.
5795295 August 18, 1998 Hellmuth et al.
5807339 September 15, 1998 Bostrom et al.
5830145 November 3, 1998 Tenhoff
5836957 November 17, 1998 Schulz et al.
5843050 December 1, 1998 Jones et al.
5843103 December 1, 1998 Wulfman
5851212 December 22, 1998 Zirps et al.
5868778 February 9, 1999 Gershony et al.
5872879 February 16, 1999 Hamm
5904651 May 18, 1999 Swanson et al.
5907425 May 25, 1999 Dickensheets et al.
5935075 August 10, 1999 Casscells et al.
5935139 August 10, 1999 Bates
5938602 August 17, 1999 Lloyd
5938671 August 17, 1999 Katoh et al.
5951482 September 14, 1999 Winston et al.
5951581 September 14, 1999 Saadat et al.
5951583 September 14, 1999 Jensen et al.
5956355 September 21, 1999 Swanson et al.
5957952 September 28, 1999 Gershony et al.
5987995 November 23, 1999 Sawatari et al.
5997558 December 7, 1999 Nash
6001112 December 14, 1999 Taylor
6007530 December 28, 1999 Dornhofer et al.
6010449 January 4, 2000 Selmon et al.
6013072 January 11, 2000 Winston et al.
6017359 January 25, 2000 Gershony et al.
6027514 February 22, 2000 Stine et al.
6032673 March 7, 2000 Savage et al.
6048349 April 11, 2000 Winston et al.
6080170 June 27, 2000 Nash et al.
6106515 August 22, 2000 Winston et al.
6110164 August 29, 2000 Vidlund
6120515 September 19, 2000 Rogers et al.
6120516 September 19, 2000 Selmon et al.
6134002 October 17, 2000 Stimson et al.
6134003 October 17, 2000 Tearney et al.
6152938 November 28, 2000 Curry
6152951 November 28, 2000 Hashimoto et al.
6160826 December 12, 2000 Swanson et al.
6175669 January 16, 2001 Colston et al.
6176871 January 23, 2001 Pathak et al.
6183432 February 6, 2001 Milo
6193676 February 27, 2001 Winston et al.
6206898 March 27, 2001 Honeycutt et al.
6228076 May 8, 2001 Winston et al.
6241744 June 5, 2001 Imran et al.
6283957 September 4, 2001 Hashimoto et al.
6285903 September 4, 2001 Rosenthal et al.
6290668 September 18, 2001 Gregory et al.
6294775 September 25, 2001 Seibel et al.
6299622 October 9, 2001 Snow et al.
6307985 October 23, 2001 Murakami et al.
6375615 April 23, 2002 Flaherty et al.
6402719 June 11, 2002 Ponzi et al.
6416527 July 9, 2002 Berg et al.
6445939 September 3, 2002 Swanson et al.
6445944 September 3, 2002 Ostrovsky
6447525 September 10, 2002 Follmer et al.
6451009 September 17, 2002 Dasilva et al.
6451036 September 17, 2002 Heitzmann et al.
6454717 September 24, 2002 Pantages et al.
6454779 September 24, 2002 Taylor
6482216 November 19, 2002 Hiblar et al.
6482217 November 19, 2002 Pintor et al.
6485413 November 26, 2002 Boppart et al.
6497649 December 24, 2002 Parker et al.
6501551 December 31, 2002 Tearney et al.
6503261 January 7, 2003 Bruneau et al.
6511458 January 28, 2003 Milo et al.
6517528 February 11, 2003 Pantages et al.
6542665 April 1, 2003 Reed et al.
6544230 April 8, 2003 Flaherty et al.
6546272 April 8, 2003 MacKinnon et al.
6551302 April 22, 2003 Rosinko et al.
6563105 May 13, 2003 Seibel et al.
6564087 May 13, 2003 Pitris et al.
6565588 May 20, 2003 Clement et al.
6572563 June 3, 2003 Ouchi et al.
6572643 June 3, 2003 Gharibadeh
6575995 June 10, 2003 Huter et al.
6579298 June 17, 2003 Bruneau et al.
6599296 July 29, 2003 Gillick et al.
6615071 September 2, 2003 Casscells, III et al.
6629953 October 7, 2003 Boyd
6638233 October 28, 2003 Corvi et al.
6645217 November 11, 2003 MacKinnon et al.
6657727 December 2, 2003 Izatt et al.
6666874 December 23, 2003 Heitzmann et al.
6673042 January 6, 2004 Samson et al.
6687010 February 3, 2004 Horii
6728571 April 27, 2004 Barbato
D489973 May 18, 2004 Root et al.
6730063 May 4, 2004 Delaney et al.
6758854 July 6, 2004 Butler et al.
6760112 July 6, 2004 Reed et al.
6800085 October 5, 2004 Selmon et al.
6818001 November 16, 2004 Wulfman et al.
6824550 November 30, 2004 Noriega et al.
6830577 December 14, 2004 Nash et al.
6845190 January 18, 2005 Smithwick et al.
6852109 February 8, 2005 Winston et al.
6853457 February 8, 2005 Bjarklev et al.
6856712 February 15, 2005 Fauver et al.
6867753 March 15, 2005 Chinthammit et al.
6879851 April 12, 2005 McNamara et al.
6947787 September 20, 2005 Webler
6961123 November 1, 2005 Wang et al.
6970732 November 29, 2005 Winston et al.
6975898 December 13, 2005 Seibel
7068878 June 27, 2006 Crossman-Bosworth et al.
7074231 July 11, 2006 Jang
7126693 October 24, 2006 Everett et al.
7172610 February 6, 2007 Heitzmann et al.
7242480 July 10, 2007 Alphonse
7261687 August 28, 2007 Yang
7288087 October 30, 2007 Winston et al.
7291146 November 6, 2007 Steinke et al.
7297131 November 20, 2007 Nita
7311723 December 25, 2007 Seibel et al.
7344546 March 18, 2008 Wulfman et al.
7366376 April 29, 2008 Shishkov et al.
7382949 June 3, 2008 Bouma et al.
7426036 September 16, 2008 Feldchtein et al.
7428001 September 23, 2008 Schowengerdt et al.
7428053 September 23, 2008 Feldchtein et al.
7455649 November 25, 2008 Root et al.
7474407 January 6, 2009 Gutin
7485127 February 3, 2009 Nistal
7488340 February 10, 2009 Kauphusman et al.
7530948 May 12, 2009 Seibel et al.
7530976 May 12, 2009 MacMahon et al.
7538859 May 26, 2009 Tearney et al.
7538886 May 26, 2009 Feldchtein
7539362 May 26, 2009 Teramura
7542145 June 2, 2009 Toida et al.
7544162 June 9, 2009 Ohkubo
7545504 June 9, 2009 Buckland et al.
7555333 June 30, 2009 Wang et al.
7577471 August 18, 2009 Camus et al.
7583872 September 1, 2009 Seibel et al.
7616986 November 10, 2009 Seibel et al.
7637885 December 29, 2009 Maschke
7674253 March 9, 2010 Fisher et al.
7682319 March 23, 2010 Martin et al.
7706863 April 27, 2010 Imanishi et al.
7728985 June 1, 2010 Feldchtein et al.
7729745 June 1, 2010 Maschke
7734332 June 8, 2010 Sher
7738945 June 15, 2010 Fauver et al.
7753852 July 13, 2010 Maschke
7771425 August 10, 2010 Dycus et al.
7776062 August 17, 2010 Bessellink et al.
7785286 August 31, 2010 Magnin et al.
7813609 October 12, 2010 Petersen et al.
7821643 October 26, 2010 Amazeen et al.
7824089 November 2, 2010 Charles
7840283 November 23, 2010 Bush et al.
7944568 May 17, 2011 Teramura et al.
7952718 May 31, 2011 Li et al.
7972299 July 5, 2011 Carter et al.
8002763 August 23, 2011 Berthiaume et al.
8059274 November 15, 2011 Splinter
8062316 November 22, 2011 Patel et al.
8068921 November 29, 2011 Prakash et al.
8313493 November 20, 2012 Fisher
8361097 January 29, 2013 Patel et al.
8548571 October 1, 2013 He et al.
8548603 October 1, 2013 Swoyer et al.
8632557 January 21, 2014 Thatcher et al.
8644913 February 4, 2014 Simpson et al.
8647335 February 11, 2014 Markus
8696695 April 15, 2014 Patel et al.
8911459 December 16, 2014 Simpson et al.
9119662 September 1, 2015 Moberg
9125562 September 8, 2015 Spencer et al.
9333007 May 10, 2016 Escudero et al.
9345398 May 24, 2016 Tachibana et al.
9345406 May 24, 2016 Spencer et al.
9345510 May 24, 2016 Patel et al.
9345511 May 24, 2016 Smith et al.
9351757 May 31, 2016 Kusleika
9498247 November 22, 2016 Patel et al.
9498600 November 22, 2016 Rosenthal et al.
9557156 January 31, 2017 Kankaria
9572492 February 21, 2017 Simpson et al.
9579157 February 28, 2017 Moberg
9592075 March 14, 2017 Simpson et al.
9642646 May 9, 2017 Patel et al.
9788790 October 17, 2017 Black et al.
9854979 January 2, 2018 Smith et al.
9918734 March 20, 2018 Patel et al.
9949754 April 24, 2018 Newhauser et al.
10052125 August 21, 2018 Rosenthal et al.
10130386 November 20, 2018 Simpson et al.
10213224 February 26, 2019 Guggenheimer et al.
10244934 April 2, 2019 Tachibana et al.
10314667 June 11, 2019 Garvey et al.
10335173 July 2, 2019 Carver et al.
10342491 July 9, 2019 Black et al.
10349974 July 16, 2019 Patel et al.
10357277 July 23, 2019 Patel et al.
10363062 July 30, 2019 Spencer et al.
10406316 September 10, 2019 Garvey et al.
10470795 November 12, 2019 Patel et al.
10548478 February 4, 2020 Simpson et al.
10568520 February 25, 2020 Patel et al.
10568655 February 25, 2020 Simpson et al.
10722121 July 28, 2020 Smith et al.
10729326 August 4, 2020 Spencer et al.
10860484 December 8, 2020 Simpson et al.
10869685 December 22, 2020 Patel et al.
10932670 March 2, 2021 Smith et al.
10952615 March 23, 2021 Kankaria
10952763 March 23, 2021 Newhauser et al.
11033190 June 15, 2021 Patel et al.
11076773 August 3, 2021 Patel et al.
11096717 August 24, 2021 Gupta et al.
11134849 October 5, 2021 Simpson et al.
11135019 October 5, 2021 Spencer et al.
11147583 October 19, 2021 Patel et al.
11206975 December 28, 2021 Tachibana et al.
11224459 January 18, 2022 Patel et al.
20010005788 June 28, 2001 McGuckin, Jr.
20010020126 September 6, 2001 Swanson et al.
20020019644 February 14, 2002 Hastings et al.
20020072706 June 13, 2002 Hiblar et al.
20020082585 June 27, 2002 Carroll et al.
20020082626 June 27, 2002 Donohoe et al.
20020097400 July 25, 2002 Jung et al.
20020111548 August 15, 2002 Swanson et al.
20020115931 August 22, 2002 Strauss et al.
20020138091 September 26, 2002 Pflueger
20020147459 October 10, 2002 Bashiri et al.
20020158547 October 31, 2002 Wood
20030002038 January 2, 2003 Mawatari
20030028100 February 6, 2003 Tearney et al.
20030032880 February 13, 2003 Moore
20030045835 March 6, 2003 Anderson et al.
20030095248 May 22, 2003 Frot
20030097044 May 22, 2003 Rovegno
20030120150 June 26, 2003 Govari
20030120295 June 26, 2003 Simpson et al.
20030125756 July 3, 2003 Shturman et al.
20030125757 July 3, 2003 Patel et al.
20030125758 July 3, 2003 Simpson et al.
20030139751 July 24, 2003 Evans et al.
20030181855 September 25, 2003 Simpson et al.
20040002650 January 1, 2004 Mandrusov et al.
20040039371 February 26, 2004 Tockman et al.
20040057667 March 25, 2004 Yamada et al.
20040059257 March 25, 2004 Gaber
20040082850 April 29, 2004 Bonner et al.
20040092915 May 13, 2004 Levatter
20040093001 May 13, 2004 Hamada
20040147934 July 29, 2004 Kiester
20040167553 August 26, 2004 Simpson et al.
20040167554 August 26, 2004 Simpson et al.
20040181249 September 16, 2004 Torrance et al.
20040186368 September 23, 2004 Ramzipoor et al.
20040193140 September 30, 2004 Griffin et al.
20040202418 October 14, 2004 Ghiron et al.
20040220519 November 4, 2004 Wulfman et al.
20040230212 November 18, 2004 Wulfman
20040230213 November 18, 2004 Wulfman et al.
20040236312 November 25, 2004 Nistal et al.
20040243162 December 2, 2004 Wulfman et al.
20040254599 December 16, 2004 Lipoma et al.
20040260236 December 23, 2004 Manning et al.
20050020925 January 27, 2005 Kleen et al.
20050021075 January 27, 2005 Bonnette et al.
20050027199 February 3, 2005 Clarke
20050043614 February 24, 2005 Huizenga et al.
20050054947 March 10, 2005 Goldenberg
20050075660 April 7, 2005 Chu et al.
20050085708 April 21, 2005 Fauver et al.
20050085721 April 21, 2005 Fauver et al.
20050105097 May 19, 2005 Fang-Yen et al.
20050141843 June 30, 2005 Warden et al.
20050149096 July 7, 2005 Hilal et al.
20050154407 July 14, 2005 Simpson
20050159712 July 21, 2005 Andersen
20050159731 July 21, 2005 Lee
20050171478 August 4, 2005 Selmon et al.
20050177068 August 11, 2005 Simpson
20050182295 August 18, 2005 Soper et al.
20050187571 August 25, 2005 Maschke
20050192496 September 1, 2005 Maschke
20050197623 September 8, 2005 Leeflang et al.
20050201662 September 15, 2005 Petersen et al.
20050203553 September 15, 2005 Maschke
20050222519 October 6, 2005 Simpson
20050222663 October 6, 2005 Simpson et al.
20050251116 November 10, 2005 Steinke et al.
20060011820 January 19, 2006 Chow-Shing et al.
20060032508 February 16, 2006 Simpson
20060046235 March 2, 2006 Alexander
20060049587 March 9, 2006 Cornwell
20060064009 March 23, 2006 Webler et al.
20060084911 April 20, 2006 Belef et al.
20060109478 May 25, 2006 Tearney et al.
20060135870 June 22, 2006 Webler
20060173475 August 3, 2006 Lafontaine et al.
20060229646 October 12, 2006 Sparks
20060229659 October 12, 2006 Gifford et al.
20060235262 October 19, 2006 Arnal et al.
20060235366 October 19, 2006 Simpson
20060236019 October 19, 2006 Soito et al.
20060239982 October 26, 2006 Simpson
20060241503 October 26, 2006 Schmitt et al.
20060244973 November 2, 2006 Yun et al.
20060252993 November 9, 2006 Freed et al.
20060264741 November 23, 2006 Prince
20060264743 November 23, 2006 Kleen et al.
20060264907 November 23, 2006 Eskridge et al.
20070010840 January 11, 2007 Rosenthal et al.
20070015969 January 18, 2007 Feldman et al.
20070015979 January 18, 2007 Redel
20070035855 February 15, 2007 Dickensheets
20070038061 February 15, 2007 Huennekens et al.
20070038125 February 15, 2007 Kleen et al.
20070038173 February 15, 2007 Simpson
20070050019 March 1, 2007 Hyde
20070078469 April 5, 2007 Soito et al.
20070078500 April 5, 2007 Ryan et al.
20070081166 April 12, 2007 Brown et al.
20070088230 April 19, 2007 Terashi et al.
20070106155 May 10, 2007 Goodnow et al.
20070135712 June 14, 2007 Maschke
20070167710 July 19, 2007 Unal et al.
20070196926 August 23, 2007 Soito et al.
20070213618 September 13, 2007 Li et al.
20070219484 September 20, 2007 Straub
20070250080 October 25, 2007 Jones et al.
20070255252 November 1, 2007 Mehta
20070270647 November 22, 2007 Nahen et al.
20070276419 November 29, 2007 Rosenthal
20070288036 December 13, 2007 Seshadri
20070299309 December 27, 2007 Seibel et al.
20080004643 January 3, 2008 To et al.
20080004644 January 3, 2008 To et al.
20080004645 January 3, 2008 To et al.
20080004646 January 3, 2008 To et al.
20080015491 January 17, 2008 Bei et al.
20080015618 January 17, 2008 Sonnenschein et al.
20080027334 January 31, 2008 Langston
20080033396 February 7, 2008 Danek et al.
20080045986 February 21, 2008 To et al.
20080049234 February 28, 2008 Seitz
20080058629 March 6, 2008 Seibel et al.
20080065124 March 13, 2008 Olson
20080065125 March 13, 2008 Olson
20080065205 March 13, 2008 Nguyen et al.
20080095421 April 24, 2008 Sun et al.
20080103439 May 1, 2008 Torrance et al.
20080103446 May 1, 2008 Torrance et al.
20080103516 May 1, 2008 Wulfman et al.
20080132929 June 5, 2008 O'Sullivan et al.
20080139897 June 12, 2008 Ainsworth et al.
20080146942 June 19, 2008 Dala-Krishna
20080147000 June 19, 2008 Seibel et al.
20080154293 June 26, 2008 Taylor et al.
20080154296 June 26, 2008 Taylor et al.
20080177138 July 24, 2008 Courtney et al.
20080186501 August 7, 2008 Xie
20080207996 August 28, 2008 Tsai
20080221388 September 11, 2008 Seibel et al.
20080228033 September 18, 2008 Tumlinson et al.
20080243030 October 2, 2008 Seibel et al.
20080243031 October 2, 2008 Seibel et al.
20080262312 October 23, 2008 Carroll et al.
20080275485 November 6, 2008 Bonnette et al.
20080287795 November 20, 2008 Klingensmith et al.
20090018565 January 15, 2009 To et al.
20090018566 January 15, 2009 Escudero et al.
20090018567 January 15, 2009 Escudero et al.
20090024084 January 22, 2009 Khosla et al.
20090024085 January 22, 2009 To et al.
20090024191 January 22, 2009 Seibel et al.
20090028407 January 29, 2009 Seibel et al.
20090028507 January 29, 2009 Jones et al.
20090043191 February 12, 2009 Castella et al.
20090073444 March 19, 2009 Wang
20090073455 March 19, 2009 Onimura
20090076447 March 19, 2009 Casas et al.
20090093764 April 9, 2009 Pfeffer et al.
20090099641 April 16, 2009 Wu et al.
20090125019 May 14, 2009 Douglass et al.
20090135280 May 28, 2009 Johnston et al.
20090137893 May 28, 2009 Seibel et al.
20090152664 June 18, 2009 Tian et al.
20090185135 July 23, 2009 Volk
20090196477 August 6, 2009 Cense et al.
20090196554 August 6, 2009 Irisawa
20090198125 August 6, 2009 Nakabayashi et al.
20090208143 August 20, 2009 Yoon et al.
20090216180 August 27, 2009 Lee et al.
20090221904 September 3, 2009 Shealy et al.
20090221920 September 3, 2009 Boppart et al.
20090234220 September 17, 2009 Maschke
20090235396 September 17, 2009 Wang et al.
20090244485 October 1, 2009 Walsh et al.
20090244547 October 1, 2009 Ozawa
20090264826 October 22, 2009 Thompson
20090268159 October 29, 2009 Xu et al.
20090275966 November 5, 2009 Mitusina
20090284749 November 19, 2009 Johnson et al.
20090292199 November 26, 2009 Bielewicz et al.
20090306520 December 10, 2009 Schmitt et al.
20090316116 December 24, 2009 Melville et al.
20090318862 December 24, 2009 Ali et al.
20100004544 January 7, 2010 Toida
20100021926 January 28, 2010 Noordin
20100049225 February 25, 2010 To et al.
20100080016 April 1, 2010 Fukui et al.
20100082000 April 1, 2010 Honeck et al.
20100125253 May 20, 2010 Olson
20100130996 May 27, 2010 Doud et al.
20100198081 August 5, 2010 Hanlin et al.
20100217245 August 26, 2010 Prescott
20100241147 September 23, 2010 Maschke
20100253949 October 7, 2010 Adler et al.
20100292539 November 18, 2010 Lankenau et al.
20100292721 November 18, 2010 Moberg
20100312263 December 9, 2010 Moberg et al.
20100317973 December 16, 2010 Nita
20100324472 December 23, 2010 Wulfman
20110023617 February 3, 2011 Yu et al.
20110028977 February 3, 2011 Rauscher et al.
20110040238 February 17, 2011 Wulfman et al.
20110058250 March 10, 2011 Liu et al.
20110060186 March 10, 2011 Tilson et al.
20110071401 March 24, 2011 Hastings et al.
20110092955 April 21, 2011 Purdy et al.
20110106004 May 5, 2011 Eubanks et al.
20110118660 May 19, 2011 Torrance et al.
20110130777 June 2, 2011 Zhang et al.
20110137140 June 9, 2011 Tearney et al.
20110144673 June 16, 2011 Zhang et al.
20110201924 August 18, 2011 Tearney et al.
20110208222 August 25, 2011 Ljahnicky et al.
20110257478 October 20, 2011 Kleiner et al.
20110264125 October 27, 2011 Wilson et al.
20110270187 November 3, 2011 Nelson
20110295148 December 1, 2011 Destoumieux et al.
20110301625 December 8, 2011 Mauch et al.
20110319905 December 29, 2011 Palme et al.
20120002928 January 5, 2012 Irisawa
20120004506 January 5, 2012 Tearney et al.
20120123352 May 17, 2012 Fruland et al.
20120136350 May 31, 2012 Goshgarian et al.
20120203230 August 9, 2012 Adams
20120238869 September 20, 2012 Schmitt et al.
20120259337 October 11, 2012 del Rio et al.
20120277730 November 1, 2012 Salahieh et al.
20120289971 November 15, 2012 Segermark et al.
20130023865 January 24, 2013 Steinke et al.
20130035692 February 7, 2013 Sorensen et al.
20130072787 March 21, 2013 Wallace et al.
20130184549 July 18, 2013 Avitall et al.
20130211221 August 15, 2013 Sunnarborg et al.
20130223798 August 29, 2013 Jenner et al.
20130223801 August 29, 2013 Bhagavatula et al.
20130255069 October 3, 2013 Higashi et al.
20130266259 October 10, 2013 Bhagavatula et al.
20130287282 October 31, 2013 Yokota et al.
20130317519 November 28, 2013 Romo et al.
20130325003 December 5, 2013 Kapur et al.
20130331819 December 12, 2013 Rosenman et al.
20140005534 January 2, 2014 He et al.
20140046250 February 13, 2014 Jain et al.
20140128893 May 8, 2014 Guggenheimer et al.
20140187949 July 3, 2014 Zhao et al.
20140222042 August 7, 2014 Kessler et al.
20140222047 August 7, 2014 Vreeman
20140243881 August 28, 2014 Lees et al.
20140275996 September 18, 2014 Stigall
20140291985 October 2, 2014 Cabrera et al.
20140343410 November 20, 2014 Graf et al.
20140371718 December 18, 2014 Alvarez et al.
20150025310 January 22, 2015 Everingham et al.
20150036146 February 5, 2015 Staloff
20150141816 May 21, 2015 Gupta et al.
20150146211 May 28, 2015 Bhagavatula et al.
20150320975 November 12, 2015 Simpson et al.
20150327866 November 19, 2015 Eckhouse et al.
20160144155 May 26, 2016 Simpson et al.
20160310700 October 27, 2016 Drake et al.
20160354109 December 8, 2016 Guggenheimer et al.
20160354110 December 8, 2016 Guggenheimer et al.
20180207417 July 26, 2018 Zung et al.
20180364024 December 20, 2018 Baca et al.
20190021679 January 24, 2019 Christensen
20190029714 January 31, 2019 Patel et al.
20190110809 April 18, 2019 Rosenthal et al.
20190313941 October 17, 2019 Radjabi
20200060718 February 27, 2020 Patel et al.
20200069253 March 5, 2020 Black et al.
20200315654 October 8, 2020 Patel et al.
20200323553 October 15, 2020 Fernandez et al.
20210059713 March 4, 2021 Patel et al.
20210076949 March 18, 2021 Smith et al.
20210177262 June 17, 2021 Spencer et al.
20210267621 September 2, 2021 Simpson et al.
20210330345 October 28, 2021 Newhauser et al.
20210345903 November 11, 2021 Patel et al.
20220071656 March 10, 2022 Patel et al.
20220168011 June 2, 2022 Patel et al.
20220240860 August 4, 2022 Black et al.
20230225616 July 20, 2023 Patel et al.
Foreign Patent Documents
1875242 December 2006 CN
1947652 April 2007 CN
101601581 December 2009 CN
103027727 April 2013 CN
104968285 October 2015 CN
202006018883.5 February 2007 DE
0347098 December 1989 EP
0808638 November 1997 EP
0845692 November 2005 EP
1859732 November 2007 EP
2090245 August 2009 EP
2353526 September 2013 EP
2942028 November 2015 EP
3446648 February 2019 EP
S62-275425 November 1987 JP
03502060 February 1990 JP
H05501065 March 1993 JP
05103763 April 1993 JP
06027343 February 1994 JP
H07184888 July 1995 JP
07308393 November 1995 JP
2002214127 July 2002 JP
2004509695 April 2004 JP
2004516073 June 2004 JP
2005114473 April 2005 JP
2005230550 September 2005 JP
2005249704 September 2005 JP
2005533533 November 2005 JP
2008175698 July 2006 JP
2006288775 October 2006 JP
2006313158 November 2006 JP
2006526790 November 2006 JP
2006326157 December 2006 JP
200783053 April 2007 JP
200783057 April 2007 JP
2007225349 September 2007 JP
2007533361 November 2007 JP
2008023627 February 2008 JP
2008128708 June 2008 JP
2008145376 June 2008 JP
2008183208 August 2008 JP
2008253492 October 2008 JP
200914751 January 2009 JP
2009509690 March 2009 JP
200978150 April 2009 JP
2009066252 April 2009 JP
2009201969 September 2009 JP
2010042182 February 2010 JP
2010518900 June 2010 JP
2011521747 July 2011 JP
2012143558 August 2012 JP
2012229976 November 2012 JP
2012533353 December 2012 JP
2013512736 April 2013 JP
2013/524930 June 2013 JP
2015533584 November 2015 JP
2016508758 March 2016 JP
2007/0047221 May 2007 KR
2185859 July 2002 RU
2218191 December 2003 RU
WO91/17698 November 1991 WO
WO99/23958 May 1999 WO
WO00/54659 September 2000 WO
WO01/15609 March 2001 WO
WO01/76680 October 2001 WO
WO2006/133030 December 2006 WO
WO2008/005888 January 2008 WO
WO2008/029506 March 2008 WO
WO2008/042987 April 2008 WO
WO2008/051951 May 2008 WO
WO2008/065600 June 2008 WO
WO2008/086613 July 2008 WO
WO2008/087613 July 2008 WO
WO2008/151155 December 2008 WO
WO2009/005779 January 2009 WO
WO2009/006335 January 2009 WO
WO2009/009799 January 2009 WO
WO2009/009802 January 2009 WO
WO2009/023635 February 2009 WO
WO2009/024344 February 2009 WO
WO2009/094341 July 2009 WO
WO2009/140617 November 2009 WO
WO2009/148317 December 2009 WO
WO2010/039464 April 2010 WO
WO2010/056771 May 2010 WO
WO2011/044387 April 2011 WO
WO2011/062087 May 2011 WO
WO2012/057940 May 2012 WO
WO2012/061935 May 2012 WO
WO2012/123737 September 2012 WO
WO2012/166332 December 2012 WO
WO2013/033490 March 2013 WO
WO2013/056262 April 2013 WO
WO2014/077870 May 2014 WO
WO2014/093148 June 2014 WO
WO2015/074018 May 2015 WO
WO2015/101747 July 2015 WO
WO2015/120146 August 2015 WO
WO2015/165736 November 2015 WO
WO2017/007853 January 2017 WO
Other references
  • Tachibana et al.; U.S. Appl. No. 17/645,722 entitled “Atherectomy catheter drive assemblies,” filed Dec. 22, 2021, 48 pages.
  • Patel et al.; U.S. Appl. No. 17/816,673 entitled “Atherectomy catheter with serrated cutter,” filed Aug. 1, 2022, 106 pages.
  • Rosenthal et al.; U.S. Appl. No. 18/337,852 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Jun. 20, 2023, 39 pages.
  • Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005.
  • Bayer Material Science: ; Snap-Fit Joints for Plastics; 26 pages; retrieved from the Internet: ( https://web.archive.org/web/20121119232733if_/http://fab.cba.mit.edu:80/classes/S62.12/people/vemelle.noel/Plastic_Snap_fit_design.pdf) on Sep. 26, 2018.
  • Choma et al.; Sensitivity advantage of swept source and fourier domain optical coherence tomography; Optics Express; 11(18); pp. 2183-2189; Sep. 8, 2003.
  • De Boer et al.; Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography; Optics Letters; 28(21); pp. 2067-2069; Nov. 2003.
  • Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987.
  • Gonzalo et al.; Optical coherence tomography patterns of stent restenosis; Am. Heart J.; 158(2); pp. 284-293; Aug. 2009.
  • Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages.
  • Leitgeb et al.; Performance of fourier domain vs time domain optical coherence tomography; Optics Express; 11(8); pp. 889-894; Apr. 21, 2003.
  • Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990.
  • Merriam Webster; Proximal (Definition); 10 pages; retrieved from the internet (https://www.merriam-webster.com/dictionary/proximal) on Jun. 9, 2021.
  • Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages.
  • Rollins et al.; Optimal interferometer designs for optical coherence tomography; Optics Letters; 24(21); pp. 1484-1486; Nov. 1999.
  • Schmitt et al.; A new rotational thrombectomy catheter: System design and first clinical experiences; Cardiovascular and Interventional Radiology; Springer-Verlag; 22(6); pp. 504-509; Nov. 1, 1999.
  • Sharma et al.; Common-path optical coherence tomography with side-viewing bare fiber probe for endoscopic optical coherence tomography; Rev. Sci. Instrum.; vol. 78; 113102; 5 pages; Nov. 6, 2007.
  • Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages.
  • Shinkle et al.; Evaluation of stent placement and outcomes with optical coherence tomography; Interv. Cardiol.; 2(4); pp. 535-543; (manuscript version, 12 pages); Aug. 2010.
  • Stamper et al.; Plaque characterization with optical coherence tomography. Journal of the American College of Cardiology. 47(8); pp. 69-79; Apr. 18, 2006.
  • Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994.
  • Tanaka et al.; Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography; Journal of Biomedical Optics; 15(1); pp. (011104-1)-(011104-8); Jan.-Feb. 2010.
  • Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010.
  • Wikipedia; Hinge; 4 pages; retrieved from the internet (https://en.wikipedia.org/w/index.php?title=Hinge&oldid=479569345) on Jun. 9, 2021.
  • Smith et al.; U.S. Appl. No. 17/189,123 entitled “Optical pressure sensor assembly,” filed Mar. 1, 2021, 56 pages.
  • Kankaria; U.S. Appl. No. 17/209,162 entitled “Optical coherence tomography with graded index fiber for biological imaging,” filed Mar. 22, 2021.
  • Patel et al.; U.S. Appl. No. 17/347,419 entitled “Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters,” filed Jun. 14, 2021.
  • Gupta et al.; U.S. Appl. No. 17/445,648 entitled “Tissue collection device for catheter,” filed Aug. 23, 2021, 61 pages.
  • Simpson et al.; U.S. Appl. No. 17/449,867 entitled “Occlusion-crossing devices, imaging, and atherectomy devices,” filed Oct. 4, 2021, 51 pages.
  • Spencer et al.; U.S. Appl. No. 17/449,895 entitled “Occlusion-crossing devices, atherectomy devices, and imaging,” filed Oct. 4, 2021, 24 pages.
  • Patel et al.; U.S. Appl. No. 17/762,815 entitled “Atherectomy catheter with shapeable distal tip,” filed Mar. 23, 2022, 79 pages.
  • Patel.; U.S. Appl. No. 17/763,810 entitled “Occlusion-crossing devices,” filed Mar. 25, 2022, 82 pages.
  • Fernandez et al.; U.S. Appl. No. 17/747,715 entitled “Catheter device with detachable distal end,” filed May 18, 2022, 41 pages.
  • Patel et al.; U.S. Appl. No. 17/749,882 entitled “Atherectomy Catheter,” filed May 20, 2022, 149 pages.
Patent History
Patent number: 11931061
Type: Grant
Filed: Oct 12, 2021
Date of Patent: Mar 19, 2024
Patent Publication Number: 20220039828
Assignee: Avinger, Inc. (Redwood City, CA)
Inventors: Himanshu N. Patel (San Jose, CA), John B. Simpson (Woodside, CA), Ryan Radjabi (Campbell, CA)
Primary Examiner: Kelly J Bekker
Assistant Examiner: Andrew P. Restaino
Application Number: 17/450,658
Classifications
International Classification: A61B 17/3207 (20060101); A61B 1/00 (20060101); A61B 1/005 (20060101); A61B 1/313 (20060101); A61B 17/00 (20060101); A61B 17/22 (20060101); A61B 90/00 (20160101);